[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 999 0232", "website": "https://www.q32bio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti\u0096interleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb \u0096 CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Ms. Jodie Pope Morrison", "age": 48, "title": "CEO & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 860740, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee H. Kalowski M.B.A.", "age": 43, "title": "CFO & President", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 750793, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.55, "open": 1.56, "dayLow": 1.45, "dayHigh": 1.62, "regularMarketPreviousClose": 1.55, "regularMarketOpen": 1.56, "regularMarketDayLow": 1.45, "regularMarketDayHigh": 1.62, "payoutRatio": 0.0, "forwardPE": -0.2705224, "volume": 659913, "regularMarketVolume": 659913, "averageVolume": 165400, "averageVolume10days": 163280, "averageDailyVolume10Day": 163280, "bid": 1.46, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 17686520, "fiftyTwoWeekLow": 1.38, "fiftyTwoWeekHigh": 53.79, "fiftyDayAverage": 1.7115, "twoHundredDayAverage": 14.89945, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -28997458, "profitMargins": 0.0, "floatShares": 9771387, "sharesOutstanding": 12197600, "sharesShort": 384785, "sharesShortPriorMonth": 627032, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0315, "heldPercentInsiders": 0.065689996, "heldPercentInstitutions": 0.73297995, "shortRatio": 3.45, "shortPercentOfFloat": 0.1121, "impliedSharesOutstanding": 12861400, "bookValue": -0.329, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -59793000, "trailingEps": -7.57, "forwardEps": -5.36, "lastSplitFactor": "1:18", "lastSplitDate": 1711411200, "enterpriseToEbitda": 0.467, "52WeekChange": -0.9236038, "SandP52WeekChange": 0.12748289, "quoteType": "EQUITY", "currentPrice": 1.45, "targetHighPrice": 20.0, "targetLowPrice": 6.0, "targetMeanPrice": 12.0, "targetMedianPrice": 10.0, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 65483000, "totalCashPerShare": 5.369, "ebitda": -62080000, "totalDebt": 18799000, "quickRatio": 4.492, "currentRatio": 4.708, "returnOnAssets": -0.33795, "returnOnEquity": -2.67201, "grossProfits": -48251000, "freeCashflow": -48589376, "operatingCashflow": -65646000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QTTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1751067041, "regularMarketTime": 1751054400, "postMarketChangePercent": 8.96552, "postMarketPrice": 1.58, "postMarketChange": 0.13, "regularMarketChange": -0.0999999, "regularMarketDayRange": "1.45 - 1.62", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 165400, "fiftyTwoWeekLowChange": 0.07000005, "fiftyTwoWeekLowChangePercent": 0.050724674, "fiftyTwoWeekRange": "1.38 - 53.79", "fiftyTwoWeekHighChange": -52.34, "fiftyTwoWeekHighChangePercent": -0.9730433, "fiftyTwoWeekChangePercent": -92.360374, "earningsTimestamp": 1746701947, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -7.57, "epsForward": -5.36, "fiftyDayAverageChange": -0.2615, "fiftyDayAverageChangePercent": -0.15278995, "regularMarketChangePercent": -6.45161, "regularMarketPrice": 1.45, "exchange": "NCM", "messageBoardId": "finmb_669405676", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Q32 Bio Inc.", "longName": "Q32 Bio Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1522243800000, "twoHundredDayAverageChange": -13.4494505, "twoHundredDayAverageChangePercent": -0.902681, "priceToBook": -4.407295, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "displayName": "Q32 Bio", "trailingPegRatio": null, "__fetch_time": "2025-06-28"}]